American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6413)
  2. Solid Tumor Oncology Division (5551)
  3. Survivorship Research (2002)
  4. Genitourinary Oncology Service (1770)
  5. Surgery (1645)
  6. Epidemiology and Biostatistics (1500)
  7. GSK Faculty (1390)
  8. Population Sciences Research Program (1384)
  9. Gastrointestinal Oncology Service (1358)
  10. Hematologic Malignancies, Division of (1286)
Search Within
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2591)
  3. Editorial (81)
  4. Review (70)
  5. Guidelines (55)
  6. Correspondence (51)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6413)
  2. Solid Tumor Oncology Division (5551)
  3. Survivorship Research (2002)
  4. Genitourinary Oncology Service (1770)
  5. Surgery (1645)
  6. Epidemiology and Biostatistics (1500)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (310)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (307)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8715)
  2. JCO Precision Oncology (174)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (54)
  6. JCO Oncology Practice (13)

More Publications

Results (9199)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304
    Meeting Abstract

    Rudin, C. M.; Mountzios, G. S.; Sun, L.; Cho, B. C.; Demirci, U.; Baka, S.; Gumus, M.; Lugini, A.; Ciuleanu, T. E.; Ahn, M. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase 3 AMPLITUDE trial: Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) for metastatic castration-sensitive prostate cancer (mCSPC) patients (pts) with alterations in homologous recombination repair (HRR) genes
    Meeting Abstract

    Attard, G.; Agarwal, N.; Graff, J. N.; Sandhu, S.; Efstathiou, E.; Özgüroğlu, M.; de Santana Gomes, A. J. P.; Vianna, K. C. M.; Luo, H.; Cheng, H. H.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7)
    Meeting Abstract

    Mahner, S.; Heitz, F.; Salehi, S.; Reuss, A.; Guyon, F.; Du Bois, A.; Harter, P.; Fotopoulou, C.; Querleu, D.; Mosgaard, B. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • First-line encorafenib + cetuximab + mFOLFOX6 in BRAF V600E-mutant metastatic colorectal cancer (BREAKWATER): Progression-free survival and updated overall survival analyses
    Meeting Abstract

    Elez, E.; Yoshino, T.; Shen, L.; Lonardi, S.; Van Cutsem, E.; Eng, C.; Kim, T. W.; Wasan, H. S.; Desai, J.; Ciardiello, F.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Association between empirical dietary inflammatory pattern (EDIP) and survival in patients with stage III colon cancer: Findings from CALGB/SWOG 80702 (Alliance)
    Meeting Abstract

    Char, S. K.; Shi, Q.; Zemla, T.; Ma, C.; Cheng, E.; Kumthekar, P.; Guthrie, K. A.; Couture, F.; Kuebler, J. P.; Kumar, P.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • ENLIGHTED phase 3 study: Interim results of efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) in the treatment of low-grade upper tract urothelial cancer (LG UTUC)
    Meeting Abstract

    Margulis, V.; Kaufman, R. P. Jr; Marcq, G.; Shvero, A.; Shore, N. D.; Psutka, S. P.; Uchio, E. M.; Djaladat, H.; Raman, J. D.; Shabsigh, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • NAPOLI 3, a phase 3 study of NALIRIFOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Final overall survival (OS) analysis and characteristics of the long-term survivors
    Meeting Abstract

    Chung, V.; Kochenderfer, M. D.; Natarajan, N.; Williams, G. R.; Laursen, A. A.; Cockrum, P.; Rhodes, W.; Surinach, A.; Zhang, L.; Li, J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Hyddmark, E. M. V.; Berry, D. A.; Berry, N. S.; Colman, H.; de Groot, J. F.; Ellingson, B. M.; Gan, H. K.; Johnson, A.; Lassman, A. B.; Lim, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • FORTE: A phase 2 master protocol assessing plixorafenib for BRAF-altered cancers
    Meeting Abstract

    Schreck, K. C.; De La Fuente, M. I.; Rine, J.; Kline, I.; Shephard, S. P.; Ahnert, J. R.; Sherman, E. J.; Yaeger, R.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC)
    Meeting Abstract

    Sinicrope, F. A.; Ou, F. S.; Arnold, D.; Peters, W.; Behrens, R. J.; Lieu, C. H.; Matin, K.; Cohen, D. J.; Potter, S. L.; Frankel, W. L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save